FAS信号通路对于嵌合抗原受体（CAR）T细胞的持久性至关重要。 - Suppr

Suppr

超能文献

FAS signalling pathway is crucial for CAR T cell persistence.

作者信息

Loves Robyn, Grunebaum Eyal

机构信息

Preprint Club, Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

出版信息

Nat Rev Immunol. 2024 Jun;24(6):380. doi: 10.1038/s41577-024-01038-0.

DOI:10.1038/s41577-024-01038-0

PMID:38671171

Abstract

摘要

相似文献

FAS signalling pathway is crucial for CAR T cell persistence.

Nat Rev Immunol. 2024 Jun;24(6):380. doi: 10.1038/s41577-024-01038-0.

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells.

Int J Mol Sci. 2019 Mar 14;20(6):1283. doi: 10.3390/ijms20061283.

CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30 and CD30 Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions.

Cancer Immunol Res. 2018 Oct;6(10):1274-1287. doi: 10.1158/2326-6066.CIR-18-0065. Epub 2018 Aug 7.

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.

J Vis Exp. 2019 Dec 17(154). doi: 10.3791/59949.

The making and function of CAR cells.

Immunol Lett. 2019 Aug;212:53-69. doi: 10.1016/j.imlet.2019.06.002. Epub 2019 Jun 7.

A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.

Cancer Discov. 2021 Mar;11(3):599-613. doi: 10.1158/2159-8290.CD-20-0756. Epub 2020 Dec 17.

Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.

Front Immunol. 2020 Apr 22;11:702. doi: 10.3389/fimmu.2020.00702. eCollection 2020.

CAR T-cells for relapsed B-cell ALL in adults.

Lancet Oncol. 2018 Mar;19(3):e143. doi: 10.1016/S1470-2045(18)30086-X. Epub 2018 Feb 9.

CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms.

BioDrugs. 2019 Dec;33(6):647-659. doi: 10.1007/s40259-019-00384-z.

Generation of CAR-T Cells for Cancer Immunotherapy.

Methods Mol Biol. 2019;1884:349-360. doi: 10.1007/978-1-4939-8885-3_24.

引用本文的文献

Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.

Cells. 2024 May 27;13(11):924. doi: 10.3390/cells13110924.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

FAS signalling pathway is crucial for CAR T cell persistence.

Nat Rev Immunol. 2024 Jun;24(6):380. doi: 10.1038/s41577-024-01038-0.

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells.

Int J Mol Sci. 2019 Mar 14;20(6):1283. doi: 10.3390/ijms20061283.

CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30 and CD30 Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions.

Cancer Immunol Res. 2018 Oct;6(10):1274-1287. doi: 10.1158/2326-6066.CIR-18-0065. Epub 2018 Aug 7.

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.

J Vis Exp. 2019 Dec 17(154). doi: 10.3791/59949.

The making and function of CAR cells.

Immunol Lett. 2019 Aug;212:53-69. doi: 10.1016/j.imlet.2019.06.002. Epub 2019 Jun 7.

A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.

Cancer Discov. 2021 Mar;11(3):599-613. doi: 10.1158/2159-8290.CD-20-0756. Epub 2020 Dec 17.

Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.

Front Immunol. 2020 Apr 22;11:702. doi: 10.3389/fimmu.2020.00702. eCollection 2020.

CAR T-cells for relapsed B-cell ALL in adults.

Lancet Oncol. 2018 Mar;19(3):e143. doi: 10.1016/S1470-2045(18)30086-X. Epub 2018 Feb 9.

CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms.

BioDrugs. 2019 Dec;33(6):647-659. doi: 10.1007/s40259-019-00384-z.

Generation of CAR-T Cells for Cancer Immunotherapy.

Methods Mol Biol. 2019;1884:349-360. doi: 10.1007/978-1-4939-8885-3_24.

引用本文的文献

Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.

Cells. 2024 May 27;13(11):924. doi: 10.3390/cells13110924.